{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:08:14Z","timestamp":1789664894872,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postdoctor Research Fund of West China Hospital, Sichuan University","award":["NO. 2024HXBH120 to Yi Shen"],"award-info":[{"award-number":["NO. 2024HXBH120 to Yi Shen"]}]},{"name":"135 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["No. ZYYC23001 to Jingping Liu"],"award-info":[{"award-number":["No. ZYYC23001 to Jingping Liu"]}]},{"name":"135 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["No. ZYGD23031 to Li Yang"],"award-info":[{"award-number":["No. ZYGD23031 to Li Yang"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03940-8","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:01:42Z","timestamp":1767016902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeted blockade of extracellular vesicles-mediated profibrotic vicious circle using EVs-based dual-drug delivery system to prevent liver fibrosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Jie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoting","family":"Men","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linling","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"6853","key":"3940_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/bmj.305.6853.537","volume":"305","author":"AD Burt","year":"1992","unstructured":"Burt AD. Liver fibrosis. BMJ. 1992;305(6853):537\u20138.","journal-title":"BMJ"},{"issue":"3","key":"3940_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3940_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0168-8278(89)90170-0","volume":"8","author":"G Biagini","year":"1989","unstructured":"Biagini G, Ballardini G. Liver fibrosis and extracellular matrix. J Hepatol. 1989;8(1):115\u201324.","journal-title":"J Hepatol"},{"key":"3940_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol"},{"issue":"10","key":"3940_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20(10):633\u201346.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3940_CR6","doi-asserted-by":"publisher","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","volume":"176","author":"S Kumar","year":"2021","unstructured":"Kumar S, et al. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev. 2021;176:113869.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3940_CR7","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.","journal-title":"J Extracell Vesicles"},{"key":"3940_CR8","doi-asserted-by":"publisher","first-page":"113816","DOI":"10.1016\/j.addr.2021.05.026","volume":"175","author":"E Kostallari","year":"2021","unstructured":"Kostallari E, et al. Role of extracellular vesicles in liver diseases and their therapeutic potential. Adv Drug Deliv Rev. 2021;175:113816.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"3940_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrgastro.2017.71","volume":"14","author":"G Szabo","year":"2017","unstructured":"Szabo G, Momen-Heravi F. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2017;14(8):455\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"3940_CR10","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","volume":"34","author":"H Gao","year":"2022","unstructured":"Gao H, et al. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis. Cell Metab. 2022;34(8):1201\u2013e12135.","journal-title":"Cell Metab"},{"issue":"4","key":"3940_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/hep.32662","volume":"77","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. Hepatology. 2023;77(4):1181\u201397.","journal-title":"Hepatology"},{"issue":"45","key":"3940_CR12","doi-asserted-by":"publisher","first-page":"eabh1541","DOI":"10.1126\/sciadv.abh1541","volume":"7","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD. Sci Adv. 2021;7(45):eabh1541.","journal-title":"Sci Adv"},{"issue":"6","key":"3940_CR13","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jhep.2023.08.023","volume":"79","author":"X Chen","year":"2023","unstructured":"Chen X, et al. Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated Inhibition of cellular cholesterol efflux. J Hepatol. 2023;79(6):1491\u2013501.","journal-title":"J Hepatol"},{"issue":"2","key":"3940_CR14","doi-asserted-by":"publisher","first-page":"e12040","DOI":"10.1002\/jev2.12040","volume":"10","author":"S Jung","year":"2020","unstructured":"Jung S, et al. Efficient and reproducible depletion of hepatitis B virus from plasma derived extracellular vesicles. J Extracell Vesicles. 2020;10(2):e12040.","journal-title":"J Extracell Vesicles"},{"issue":"21","key":"3940_CR15","doi-asserted-by":"publisher","first-page":"e2415556","DOI":"10.1002\/advs.202415556","volume":"12","author":"M Zhao","year":"2025","unstructured":"Zhao M, et al. Vivo reprogramming of tissue-Derived extracellular vesicles for treating chronic tissue injury through metabolic engineering. Adv Sci (Weinh). 2025;12(21):e2415556.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"3940_CR16","doi-asserted-by":"publisher","first-page":"e12320","DOI":"10.1002\/jev2.12320","volume":"12","author":"X Zhou","year":"2023","unstructured":"Zhou X, et al. MitoEVs: A new player in multiple disease pathology and treatment. J Extracell Vesicles. 2023;12(4):e12320.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"3940_CR17","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1021\/acsami.3c12776","volume":"16","author":"Q Hu","year":"2024","unstructured":"Hu Q, et al. Integrin-targeted theranostic nanoparticles for clinical MRI-traceable treatment of liver fibrosis. ACS Appl Mater Interfaces. 2024;16(2):2012\u201326.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3940_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski M, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19\u201330. sup pp 1\u201313.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"3940_CR19","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.cmet.2021.06.005","volume":"33","author":"A Loft","year":"2021","unstructured":"Loft A, et al. Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication. Cell Metab. 2021;33(8):1685\u2013e17009.","journal-title":"Cell Metab"},{"issue":"1","key":"3940_CR20","doi-asserted-by":"publisher","first-page":"1461505","DOI":"10.1080\/20013078.2018.1461505","volume":"7","author":"L Chen","year":"2018","unstructured":"Chen L, et al. Therapeutic effects of serum extracellular vesicles in liver fibrosis. J Extracell Vesicles. 2018;7(1):1461505.","journal-title":"J Extracell Vesicles"},{"key":"3940_CR21","doi-asserted-by":"publisher","first-page":"109540","DOI":"10.1016\/j.intimp.2022.109540","volume":"114","author":"M Shen","year":"2023","unstructured":"Shen M, et al. Myeloid-derived suppressor cells ameliorate liver mitochondrial damage to protect against autoimmune hepatitis by releasing small extracellular vesicles. Int Immunopharmacol. 2023;114:109540.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"3940_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCRESAHA.122.321939","volume":"132","author":"T Koide","year":"2023","unstructured":"Koide T, et al. Circulating extracellular Vesicle-Propagated MicroRNA signature as a vascular calcification factor in chronic kidney disease. Circ Res. 2023;132(4):415\u201331.","journal-title":"Circ Res"},{"issue":"9","key":"3940_CR23","doi-asserted-by":"publisher","first-page":"e2410439","DOI":"10.1002\/advs.202410439","volume":"12","author":"X Fan","year":"2025","unstructured":"Fan X, et al. Liver-secreted extracellular vesicles promote cirrhosis\u2010associated skeletal muscle injury through mtDNA\u2010cGAS\/STING axis. Adv Sci. 2025;12(9):e2410439. https:\/\/doi.org\/10.1002\/advs.202410439.","journal-title":"Adv Sci"},{"issue":"7","key":"3940_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"245","key":"3940_CR25","doi-asserted-by":"publisher","first-page":"245sr2","DOI":"10.1126\/scitranslmed.3005975","volume":"6","author":"SN Bhatia","year":"2014","unstructured":"Bhatia SN, et al. Cell and tissue engineering for liver disease. Sci Transl Med. 2014;6(245):245sr2.","journal-title":"Sci Transl Med"},{"key":"3940_CR26","doi-asserted-by":"publisher","first-page":"116363","DOI":"10.1016\/j.ecoenv.2024.116363","volume":"277","author":"L Yang","year":"2024","unstructured":"Yang L, et al. Aflatoxin B(1)-exposed hepatocyte-derived extracellular vesicles: initiating hepatic stellate cell-mediated liver fibrosis through a p53-Parkin-dependent mitophagy pathway. Ecotoxicol Environ Saf. 2024;277:116363.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"3940_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3350\/cmh.2021.0390","volume":"28","author":"Y Lee","year":"2022","unstructured":"Lee Y, Kim JH. The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology. Clin Mol Hepatol. 2022;28(4):706\u201324.","journal-title":"Clin Mol Hepatol"},{"key":"3940_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27\u201342.","journal-title":"Adv Drug Deliv Rev"},{"key":"3940_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jconrel.2022.06.063","volume":"349","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections. J Control Release. 2022;349:118\u201332.","journal-title":"J Control Release"},{"issue":"5","key":"3940_CR30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41590-024-01804-1","volume":"25","author":"N Fortelny","year":"2024","unstructured":"Fortelny N, et al. JAK-STAT signaling maintains homeostasis in T cells and macrophages. Nat Immunol. 2024;25(5):847\u201359.","journal-title":"Nat Immunol"},{"issue":"1","key":"3940_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/biof.1057","volume":"39","author":"L Vera-Ramirez","year":"2013","unstructured":"Vera-Ramirez L, et al. Curcumin and liver disease. BioFactors. 2013;39(1):88\u2013100.","journal-title":"BioFactors"},{"key":"3940_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jconrel.2022.11.017","volume":"352","author":"S Liu","year":"2022","unstructured":"Liu S, et al. Improving the circulation time and renal therapeutic potency of extracellular vesicles using an endogenous ligand binding strategy. J Controlled Release. 2022;352:1009\u201323.","journal-title":"J Controlled Release"},{"issue":"10","key":"3940_CR33","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41575-023-00832-w","volume":"20","author":"S Sharma","year":"2023","unstructured":"Sharma S, Guillou DL, Chen JY. Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20(10):662\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3940_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol. 2021;74(1):156\u201367.","journal-title":"J Hepatol"},{"issue":"1","key":"3940_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jhep.2009.03.024","volume":"51","author":"JX Jiang","year":"2009","unstructured":"Jiang JX, et al. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK\/STAT and Akt\/NF-kappaB-dependent pathways. J Hepatol. 2009;51(1):139\u201348.","journal-title":"J Hepatol"},{"issue":"5","key":"3940_CR36","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60(5):1090\u20136.","journal-title":"J Hepatol"},{"issue":"4","key":"3940_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"3940_CR38","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","volume":"63","author":"P Gissen","year":"2015","unstructured":"Gissen P, Arias IM. Structural and functional hepatocyte polarity and liver disease. J Hepatol. 2015;63(4):1023\u201337.","journal-title":"J Hepatol"},{"issue":"2","key":"3940_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/hep.28644","volume":"64","author":"W Seo","year":"2016","unstructured":"Seo W, et al. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by \u03b3\u03b4 T cells in liver fibrosis. Hepatology. 2016;64(2):616\u201331.","journal-title":"Hepatology"},{"issue":"8","key":"3940_CR40","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1038\/s41401-021-00843-w","volume":"43","author":"YJ Li","year":"2022","unstructured":"Li YJ, et al. Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles. Acta Pharmacol Sin. 2022;43(8):2026\u201341.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"3940_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, et al. Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sinica B. 2022;12(1):18\u201332.","journal-title":"Acta Pharm Sinica B"},{"issue":"1","key":"3940_CR42","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","volume":"14","author":"Q Ye","year":"2023","unstructured":"Ye Q, et al. Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice. Nat Commun. 2023;14(1):1402. https:\/\/doi.org\/10.1038\/s41467-023-37142-3.","journal-title":"Nat Commun"},{"issue":"2","key":"3940_CR43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1124\/pr.119.018440","volume":"72","author":"U Bharadwaj","year":"2020","unstructured":"Bharadwaj U, et al. Targeting Janus kinases and signal transducer and activator of transcription 3 to treat Inflammation, Fibrosis, and cancer: Rationale, Progress, and caution. Pharmacol Rev. 2020;72(2):486\u2013526.","journal-title":"Pharmacol Rev"},{"key":"3940_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semcancer.2024.04.002","volume":"101","author":"EM Vaiaki","year":"2024","unstructured":"Vaiaki EM, Falasca M. Comparative analysis of the minimal information for studies of extracellular vesicles guidelines: advancements and implications for extracellular vesicle research. Semin Cancer Biol. 2024;101:12\u201324.","journal-title":"Semin Cancer Biol"},{"issue":"33","key":"3940_CR45","doi-asserted-by":"publisher","first-page":"e2300602","DOI":"10.1002\/adma.202300602","volume":"35","author":"P Lou","year":"2023","unstructured":"Lou P, et al. Neonatal-Tissue-Derived extracellular vesicle therapy (NEXT): A potent strategy for precision regenerative medicine. Adv Mater. 2023;35(33):e2300602.","journal-title":"Adv Mater"},{"issue":"10","key":"3940_CR46","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1016\/j.apsb.2024.06.027","volume":"14","author":"K Lv","year":"2024","unstructured":"Lv K, et al. Disease-derived circulating extracellular vesicle preconditioning: a promising strategy for precision mesenchymal stem cell therapy. Acta Pharm Sin B. 2024;14(10):4526\u201343. https:\/\/doi.org\/10.1016\/j.apsb.2024.06.027.","journal-title":"Acta Pharm Sin B"},{"issue":"17","key":"3940_CR47","doi-asserted-by":"publisher","first-page":"e2212206","DOI":"10.1002\/adma.202212206","volume":"35","author":"F Li","year":"2023","unstructured":"Li F, et al. Restoration of sinusoid fenestrae followed by targeted nanoassembly delivery of an Anti-Fibrotic agent improves treatment efficacy in liver fibrosis. Adv Mater. 2023;35(17):e2212206.","journal-title":"Adv Mater"},{"key":"3940_CR48","doi-asserted-by":"crossref","unstructured":"Patel T, Yan IK, Ishiguro K. Isolation of tissue extracellular vesicles from the liver. J Visualized Experiments, 2019(150):e58649.","DOI":"10.3791\/58649"},{"issue":"8","key":"3940_CR49","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41422-018-0060-4","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, et al. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res. 2018;28(8):862\u20134.","journal-title":"Cell Res"},{"key":"3940_CR50","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.2147\/IJN.S472086","volume":"19","author":"M Shen","year":"2024","unstructured":"Shen M, et al. Metabolic reprogramming of CD4\u2009+\u2009T cells by mesenchymal stem Cell-Derived extracellular vesicles attenuates autoimmune hepatitis through mitochondrial protein transfer. Int J Nanomed. 2024;19:9799\u2013819.","journal-title":"Int J Nanomed"},{"key":"3940_CR51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","volume":"347","author":"I Kimiz-Gebologlu","year":"2022","unstructured":"Kimiz-Gebologlu I, Oncel SS. Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J Control Release. 2022;347:533\u201343.","journal-title":"J Control Release"},{"issue":"7\u20139","key":"3940_CR52","first-page":"670","volume":"38","author":"H Kojima","year":"2023","unstructured":"Kojima H, et al. CD4(+) T cell NRF2 signaling improves liver transplantation outcomes by modulating T cell activation and differentiation. Antioxid Redox Signal. 2023;38(7\u20139):670\u201383.","journal-title":"Antioxid Redox Signal"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03940-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03940-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03940-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T15:05:22Z","timestamp":1769785522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03940-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3940"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03940-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Samples were collected from both healthy individuals and patients with cirrhosis. The study was approved by the Ethics Committee of West China Hospital, Sichuan University. All healthy individuals and patients with cirrhosis signed informed consent forms.The animal experiments were approved by the Animal Care and Use Committee of West China Hospital, Sichuan University (NO. 20221121008). C57BL\/6 were purchased from the GemPharmatech Co.,Ltd.(Chengdu, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}